Most cited papers from Q-Biologicals (Belgium)

Q-Biologicals (Belgium)

What are the most cited papers from Q-Biologicals (Belgium)?

The most cited paper from Q-Biologicals (Belgium) is "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017" (Christina Fitzmaurice et al., 2019), with 2,699 citations. Next come "The Tn 3 -family of Replicative Transposons" (147) and "A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers" (146).

Published TypeFieldAccessAuthorsCitations

Showing 40 of 40 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors	27 Sep 2019	2,699
2	The Tn 3 -family of Replicative Transposons Émilien Nicolas, Michaël Lambin, Damien Dandoy et al. · Microbiology Spectrum Open access	29 Jun 2015	147
3	A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers Rigmor Thorstensson, Birger Trollfors, Nabil G. Al‐Tawil et al. · PLoS ONE Open access	8 Jan 2014	146
4	Septal and lateral wall localization of PBP5, the major D,D‐carboxypeptidase of Escherichia coli, requires substrate recognition and membrane attachment Lakshmi‐Prasad Potluri, Aneta Karczmarek, Jolanda Verheul et al. · Molecular Microbiology Open access	7 Jun 2010	93
5	Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen et al. · BMJ Open Open access	Aug 2017	90
6	Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins Luis Eduardo Rivera, Lourdes Peña, Isabelle Stainier et al. · Vaccine Open access	19 Oct 2011	81
7	A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination Thierry Van Effelterre, Matthew R. Moore, Frederik L. P. Fierens et al. · Vaccine	31 Mar 2010	80
8	Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile Ziad Ahmed Memish, Ghassan S. Dbaibo, May Montellano et al. · The Pediatric Infectious Disease Journal	28 Jan 2011	54
9	The splicing factor ASF/SF2 is associated with TIA‐1‐related/TIA‐1‐containing ribonucleoproteic complexes and contributes to post‐transcriptional repression of gene expression Nathalie Delestienne, Corinne Wauquier, Romuald Soin et al. · FEBS Journal	May 2010	47
10	A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries Sebastián García Martí, Lisandro Damián Colantonio, Ariel Bardach et al. · Cost Effectiveness and Resource Allocation Open access	2013	44
11	Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile Huynh Anh Hong, Krisztina Hitri, Siamand Hosseini et al. · Infection and Immunity Open access	7 Feb 2017	43
12	Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose Keith P. Klugman, Shabir Ahmed Madhi, Richard Adebayo Adegbola et al. · Vaccine	16 Mar 2011	36
13	An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope Douglas F. Nixon, Stéphane Huet, Jonathan Rothbard et al. · AIDS	Sep 1990	35
14	Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age Cosette Marie Wheeler, Bryan M. Harvey, Michael E. Pichichero et al. · The Pediatric Infectious Disease Journal	4 Aug 2011	34
15	Determination of the dried product resistance variability and its influence on the product temperature in pharmaceutical freeze-drying Bernadette Scutellà, Ioan-Cristian Trelea, Erwan Bourlès et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access	7 May 2018	32
16	Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately Roland Saenger, Gudrun Maechler, M. Potreck et al. · Vaccine	28 Sep 2004	31
17	Separate structural and functional domains of Tn4430 transposase contribute to target immunity Michaël Lambin, Émilien Nicolas, Cédric A. Oger et al. · Molecular Microbiology	10 Jan 2012	29
18	Lessons from an online vaccine communication project Gary Finnegan, Daphne E. Holt, Peter M B English et al. · Vaccine	19 Jun 2018	27
19	Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8+T-cell immunity Matthew D. Brown, Robbert van der Most, Justin B. Vivian et al. · OncoImmunology Open access	Oct 2012	26
20	Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age Mark M. Blatter, Nicola P. Klein, Julie S. Shepard et al. · The Pediatric Infectious Disease Journal	23 May 2012	24
21	Stent design back in the picture: an engineering perspective on longitudinal stent compression Peter Mortier, Matthieu De Beule · EuroIntervention	Nov 2011	23
22	Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A Sandrine Reigadas, Bernard Masquelier, Christina Calmels et al. · Antimicrobial Agents and Chemotherapy Open access	17 May 2011	23
23	Does stroke-associated pneumonia play an important role on risk of in-hospital mortality associated with severe stroke? A four-way decomposition analysis of a national cohort of stroke patients Matthew Gittins, M. Chaves, Andy Vail et al. · International Journal of Stroke Open access	12 May 2023	21
24	Combining sound with tongue stimulation for the treatment of tinnitus: a multi-site single-arm controlled pivotal trial Michaël Boedts, Andreas Buechner, Shih Khoo et al. · Nature Communications Open access	19 Aug 2024	17
25	Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy Carla Vinals, Swann Gaulis, Thierry G. Coche · Vaccine	Mar 2001	14
26	Nonclinical Testing of Vaccines: Report from a Workshop Jan Willem van der Laan, Roy Ph. Forster, Brian J. Ledwith et al. · Drug Information Journal	2009	13
27	Otite moyenne aiguë en pédiatrie ambulatoire : caractéristiques épidémiologiques et cliniques après l’introduction du vaccin antipneumococcique conjugué 7 valent (PCV7) Corinne Lévy, Franck Thollot, François Corrard et al. · Archives de Pédiatrie	Jun 2011	10
28	Antibody Persistence and Immune Memory 4 Years Post‐Vaccination With Combined Hepatitis A and B Vaccine in Adults Aged Over 40 Years Roman Chlíbek, Frank von Sonnenburg, Pierre Van Damme et al. · Journal of Travel Medicine	8 Feb 2011	9
29	Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice Arwen F. Altenburg, Sofia E. Magnusson, Fred T. Bosman et al. · Clinical & Experimental Immunology Open access	30 Jun 2017	8
30	Archeological treasures protection based on early forest wildfire multi-band imaging detection system Benedict Gouverneur, Steven Verstockt, Eric Pauwels et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper	24 Oct 2012	7
31	Preparation of chiral isoxazole carbinols via catalytic asymmetric Corey-Bakshi-Shibata reduction. Nicholas R. Natale, Kevin C. Rider, David J. Burkhart et al. · ARKIVOC Open access	16 Apr 2010	7
32	Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women Linda O'Neal Eckert, Christine Elizabeth Jones, Alisa B Kachikis et al. · Vaccine Open access	11 May 2020	5
33	Mixing of diphtheria, tetanus and acellular pertussis (DTaP) vaccines in a population of children in managed care Cristina Masseria, Ami R. Buikema, Fang Liu et al. · Human Vaccines & Immunotherapeutics Open access	25 Feb 2015	4
34	530 Persistence of Immune Response to Candidate Meningococcal Serogroups A, C, W-135, Y Tetanus Toxoid-Conjugated Vaccine (MenACWY-TT) up to 42 Months Following Primary Vaccination Lars Jørgen Østergaard, Véronique Bianco, Marie Van der Wielen et al. · Pediatric Research	12 Oct 2010	4
35	P2.120 Incidence and Risk Factors of Herpes Zoster Among HIV-Positive Patients in the Cohort of the German Competence Network For HIV/AIDS (KompNet) Claudia Michalik, Klaus Jansen, B Haastert et al. · Sexually Transmitted Infections Open access	Jul 2013	2
36	Stability post-licensure: Compatibility container content – A practical case study Michael Duchêne, L. Jeanmart, B. Slegers · Biologicals	30 Aug 2009	1
37	Pricing the Advance Market Commitment Jean Stéphenne · The Lancet Open access	May 2011	1
38	pH, part1. pH measurement good practice Dominique Louvel, Christine Barbier, Marie Dominique Blanchin et al. · HAL (Le Centre pour la Communication Scientifique Directe)	2007	0
39	Strategy for the safety assessment of residuals and contaminants in vaccines Lawrence M. Segal, Micaela C. Damsten · Toxicology Letters	26 Jul 2011	0
40	Hepatttis B Vaccine in Yeast Danièle Kohl · Nature Biotechnology Open access	Mar 1988	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.